Angus H. Forster
37 Kent Street
Woolloongabba, QLD 4102, Australia
Woolloongabba, QLD 4102, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy Adults.
Journal: Vaccines
Published: September 23, 2025
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 07, 2024
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 17, 2023
Immunogenicity, safety, usability and acceptability of microarray patches for vaccination: a systematic review and meta-analysis.
Journal: BMJ global health
Published: March 09, 2023
Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer's perspective.
Journal: Human vaccines & immunotherapeutics
Published: March 31, 2022
Usability, acceptability, and feasibility of a High-Density Microarray Patch (HD-MAP) applicator as a delivery method for vaccination in clinical settings.
Journal: Human vaccines & immunotherapeutics
Published: January 31, 2022
Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the NanopatchTM Microneedle Delivery System.
Journal: Human vaccines & immunotherapeutics
Published: May 07, 2021
Erratum: Author Correction: M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP).
Journal: NPJ vaccines
Published: September 18, 2020
Last Updated: 09/26/2026